These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26458049)

  • 1. Genes associated with diabetes: potential for novel therapeutic targets?
    Hara K; Kadowaki T; Odawara M
    Expert Opin Ther Targets; 2016; 20(3):255-67. PubMed ID: 26458049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic architecture of type 2 diabetes.
    Hara K; Shojima N; Hosoe J; Kadowaki T
    Biochem Biophys Res Commun; 2014 Sep; 452(2):213-20. PubMed ID: 25111817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk.
    Segrè AV; Wei N; ; ; Altshuler D; Florez JC
    Diabetes; 2015 Apr; 64(4):1470-83. PubMed ID: 25368101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targetting PED/PEA-15 for diabetes treatment.
    Fiory F; Spinelli R; Raciti GA; Parrillo L; D'esposito V; Formisano P; Miele C; Beguinot F
    Expert Opin Ther Targets; 2017 Jun; 21(6):571-581. PubMed ID: 28395542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association studies and type 2 diabetes.
    Wheeler E; Barroso I
    Brief Funct Genomics; 2011 Mar; 10(2):52-60. PubMed ID: 21436302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoughts on the progression of type 2 diabetes drug discovery.
    Bhatt HB
    Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritising Causal Genes at Type 2 Diabetes Risk Loci.
    Grotz AK; Gloyn AL; Thomsen SK
    Curr Diab Rep; 2017 Sep; 17(9):76. PubMed ID: 28758174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
    Chang S; Chen JY; Chuang YJ; Chen BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genome-wide association in type 2 diabetes and its clinical application].
    Esparza-Castro D; Andrade-Ancira FJ; Merelo-Arias CA; Cruz M; Valladares-Salgado A
    Rev Med Inst Mex Seguro Soc; 2015; 53(5):592-9. PubMed ID: 26383809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets and candidate agents for type 2 diabetes treatment with computational bioinformatics approach.
    Wang Q; Zhao Z; Shang J; Xia W
    J Diabetes Res; 2014; 2014():763936. PubMed ID: 25401107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?
    Grant SF; Hakonarson H; Schwartz S
    Endocr Rev; 2010 Apr; 31(2):183-93. PubMed ID: 20007922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of Antidiabetic Drugs.
    Srinivasan S; Yee SW; Giacomini KM
    Adv Pharmacol; 2018; 83():361-389. PubMed ID: 29801583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel type 2 diabetes loci revealed through integration of TCF7L2 DNA occupancy and SNP association data.
    Johnson ME; Zhao J; Schug J; Deliard S; Xia Q; Guy VC; Sainz J; Kaestner KH; Wells AD; Grant SF
    BMJ Open Diabetes Res Care; 2014; 2(1):e000052. PubMed ID: 25469308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.
    Lin PI; Shuldiner AR
    Schizophr Res; 2010 Nov; 123(2-3):234-43. PubMed ID: 20832248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population.
    Qian Y; Dong M; Lu F; Li H; Jin G; Hu Z; Shen C; Shen H
    Mol Cell Endocrinol; 2015 May; 407():46-51. PubMed ID: 25749274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes: genetic data sharing to advance complex disease research.
    Flannick J; Florez JC
    Nat Rev Genet; 2016 Sep; 17(9):535-49. PubMed ID: 27402621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of type 2 diabetes: the GWAS era and future perspectives [Review].
    Imamura M; Maeda S
    Endocr J; 2011; 58(9):723-39. PubMed ID: 21778616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.
    Hu C; Jia W
    Diabetes; 2018 Jan; 67(1):3-11. PubMed ID: 29263166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.